151 related articles for article (PubMed ID: 25281525)
1. Loss of progesterone receptor links to high proliferation and increases from primary to metastatic endometrial cancer lesions.
Tangen IL; Werner HM; Berg A; Halle MK; Kusonmano K; Trovik J; Hoivik EA; Mills GB; Krakstad C; Salvesen HB
Eur J Cancer; 2014 Nov; 50(17):3003-10. PubMed ID: 25281525
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor as potential therapeutic target in metastatic endometrial cancer.
Tangen IL; Onyango TB; Kopperud R; Berg A; Halle MK; Øyan AM; Werner HM; Trovik J; Kalland KH; Salvesen HB; Krakstad C
Oncotarget; 2016 Aug; 7(31):49289-49298. PubMed ID: 27384477
[TBL] [Abstract][Full Text] [Related]
3. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
[TBL] [Abstract][Full Text] [Related]
4. Impact of oestrogen and progesterone receptor expression in the cancer cells and myometrium on survival of patients with endometrial cancer.
Tomica D; Ramić S; Danolić D; Šušnjar L; Perić-Balja M; Puljiz M
J Obstet Gynaecol; 2018 Jan; 38(1):96-102. PubMed ID: 28764605
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid synthase is a potential therapeutic target in estrogen receptor-/progesterone receptor-positive endometrioid endometrial cancer.
Rahman MT; Nakayama K; Ishikawa M; Rahman M; Katagiri H; Katagiri A; Ishibashi T; Iida K; Miyazaki K
Oncology; 2013; 84(3):166-73. PubMed ID: 23306391
[TBL] [Abstract][Full Text] [Related]
6. Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
Engelsen IB; Mannelqvist M; Stefansson IM; Carter SL; Beroukhim R; Øyan AM; Otte AP; Kalland KH; Akslen LA; Salvesen HB
Br J Cancer; 2008 May; 98(10):1662-9. PubMed ID: 18475299
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: hormone receptors in risk stratification.
Guan J; Xie L; Luo X; Yang B; Zhang H; Zhu Q; Chen X
J Gynecol Oncol; 2019 Jan; 30(1):e13. PubMed ID: 30479097
[TBL] [Abstract][Full Text] [Related]
8. Impact of hormonal biomarkers on response to hormonal therapy in advanced and recurrent endometrial cancer.
van Weelden WJ; Lalisang RI; Bulten J; Lindemann K; van Beekhuizen HJ; Trum H; Boll D; Werner HMJ; van Lonkhuijzen LRCW; Yigit R; Forsse D; Witteveen PO; Galaal K; van Ginkel A; Bignotti E; Weinberger V; Sweegers S; Kroep JR; Cabrera S; Snijders MPLM; Inda MA; Eriksson AGZ; ; Krakstad C; Romano A; van de Stolpe A; Pijnenborg JMA
Am J Obstet Gynecol; 2021 Oct; 225(4):407.e1-407.e16. PubMed ID: 34019887
[TBL] [Abstract][Full Text] [Related]
9. Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression.
Sivridis E; Giatromanolaki A; Koukourakis M; Anastasiadis P
Virchows Arch; 2001 May; 438(5):470-7. PubMed ID: 11407475
[TBL] [Abstract][Full Text] [Related]
10. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.
Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW
Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158
[TBL] [Abstract][Full Text] [Related]
11. Relationship between the expression of oestrogen receptor and progesterone receptor and
Wu C; Chen R; Xu L; Chen Y; Wang Y; Huang G; Liu J
Aging (Albany NY); 2020 Jul; 12(13):12921-12929. PubMed ID: 32639950
[TBL] [Abstract][Full Text] [Related]
12. Role of steroid receptor-associated and regulated protein in tumor progression and progesterone receptor signaling in endometrial cancer.
Liu J; Wang Z; Zhou J; Wang J; He X; Wang J
Chin Med J (Engl); 2023 Nov; 136(21):2576-2586. PubMed ID: 37144734
[TBL] [Abstract][Full Text] [Related]
13. Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer.
Yang S; Jia Y; Liu X; Winters C; Wang X; Zhang Y; Devor EJ; Hovey AM; Reyes HD; Xiao X; Xu Y; Dai D; Meng X; Thiel KW; Domann FE; Leslie KK
Oncotarget; 2014 Oct; 5(20):9783-97. PubMed ID: 25229191
[TBL] [Abstract][Full Text] [Related]
14. EphA2 overexpression is associated with lack of hormone receptor expression and poor outcome in endometrial cancer.
Kamat AA; Coffey D; Merritt WM; Nugent E; Urbauer D; Lin YG; Edwards C; Broaddus R; Coleman RL; Sood AK
Cancer; 2009 Jun; 115(12):2684-92. PubMed ID: 19396818
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the progesterone receptor by the methylation of progesterone receptor gene in endometrial cancer cells.
Ren Y; Liu X; Ma D; Feng Y; Zhong N
Cancer Genet Cytogenet; 2007 Jun; 175(2):107-16. PubMed ID: 17556066
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen regulated gene expression in normal and malignant endometrial tissue.
O'Toole SA; Dunn E; Sheppard BL; Sheils O; O'Leary JJ; Wuttke W; Seidlova-Wuttke D
Maturitas; 2005 Jun; 51(2):187-98. PubMed ID: 15917160
[TBL] [Abstract][Full Text] [Related]
17. Evolution in endometrial cancer: evidence from an immunohistochemical study.
Vandenput I; Trovik J; Leunen K; Wik E; Stefansson I; Akslen L; Moerman P; Vergote I; Salvesen H; Amant F
Int J Gynecol Cancer; 2011 Feb; 21(2):316-22. PubMed ID: 21734474
[TBL] [Abstract][Full Text] [Related]
18. Is the positivity of estrogen receptor or progesterone receptor different between type 1 and type 2 endometrial cancer?
Shen F; Gao Y; Ding J; Chen Q
Oncotarget; 2017 Jan; 8(1):506-511. PubMed ID: 27888807
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
